Medicina de laboratorio y patología

A continuación, se enumeran los ensayos clínicos actuales.

22 estudios en Medicina de laboratorio y patología
(solo estudios abiertos).

Filtra esta lista de estudios por sede, estatus, etc.

1. A Study to Establish a Living Breast Organoid Biobank for Translational Research

   Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz.

   Researchers at Mayo Clinic are developing a Biobank of adult stem cell-rich breast organoids, a new research resource to facilitate normal and cancer stem cell research. Subjects in the Biobank will provide samples of excess breast tissue, complete a health questionnaire, and allow access to medical records now and in the future. The Biobank serves as a library for researchers; instead of having to look for volunteers for each new project, researchers can use samples from the Biobank as well as share information already collected.

2. A Registry to Collect Human Bio-Specimens from Healthy Volunteers to Support Clinical Protocol Development

   Jacksonville, Fla.

   The purpose of this registry is to collect human biospecimens for the support of new clinical protocol development and produce clinical grade cells and tissue for future clinical trials.

3. Device Evaluation for Point of Care Anticoagulation Testing

   Scottsdale/Phoenix, Ariz.

   The purpose of this study is:

   • To Evaluate and validate the Roche Coaguchek XS Plus analyzer at MCA to replace the ITC Hemochron Jr. Signature + for fingerstick INR.
   • To familiarize the Coumadin Clinic nurses with the new POC device
   • To develop a compliance plan for daily operation..

4. A Study to Analyze Whole Methylome for Identification of Epigenetic Variations in Undiagnosed Congenital Disorders

   Rochester, Minn.

   The purpose of this study is to analyze genome-wide methylation patterns in DNA from patients with suspected hereditary disorders but for whom all previous genetic testing has been negative and/or equivocal.

5. A Study to Evaluate DDP3 as a Predictor of Cardiogenic Shock in Patients Presenting with Cardiac Symptoms

   Rochester, Minn.

   The purpose of this study is to evaluate whether DDP3 identifies patients at early risk of cardiogenic shock presenting with STEMI in order to benefit from more aggressive cardiology scrutiny.

    

    

6. Clinical Biochemical Genetic Assays Associated with Inborn Errors of Metabolism and Other Heritable or Congenital Conditions

   Rochester, Minn.

   The objectives of this protocol are to develop and validate clinical assays for inborn errors of metabolism (IEMs) using specimens collected from consenting individuals who have a confirmed diagnosis of an IEM or are a first degree relative of an individual with an IEM and to improve the diagnosis of IEMs by establishing and/or refining disease ranges for each analyte measured and to improve the care of these patients by reducing the number of false positive results and unnecessary follow-up.

7. A Study to Evaluate the QuantiFERON-TB Gold-Plus Test for Blood Detection of Tuberculosis without Symptoms

   Rochester, Minn.

   The purpose of this study is to evaluate the new QFT-Plus assay compared to the QFT-Gold assay and the tuberculin skin test results (as available) for the detection of tuberculosis without symptoms in high-risk patients.

                  

8. A Study to Create a Biobank of Fallopian Tube Organoids (Small, Simplified Organs) in Women Undergoing Salpingectomy (Surgical Removal of the Fallopian Tubes)

   Rochester, Minn., Jacksonville, Fla.

   The aim of this study is to develop and bank organoids for collaborative use in subsequent etiological, biomarker and chemoprevention studies that will culminate in launching chemoprevention trials at Mayo.

9. A Study of the Health Issues of Bleeding Disorders

   Rochester, Minn.

   The purpose of this study is to monitor and better understand the health issues of people with bleeding disorders.

10. Circulating Tumor Nucleic Acids to Monitor Treatment Response in Metastatic Melanoma Patients

    Scottsdale/Phoenix, Ariz.

    This project will investigate whether the analysis of nucleic acids circulating in the blood from tumors can allow real-time monitoring of treatment response to targeted therapy and immunotherapy for patients who have stage IV metastatic melanoma.